Navigation Links
Advancement in Biologic Protein Expression Webinar Hosted by Selexis SA
Date:5/29/2013

Geneva, Switzerland (PRWEB) May 29, 2013

Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today it will host a free webinar to educate scientists and researchers about the newly launched SURE CHO-Mplus™ Library to address a broad range of protein production bottlenecks, including metabolic limitations, trafficking backlogs, improper folding and altered post-translational modifications to boost the overall expression of therapeutic protein drugs.

Entitled “The Selexis SURE CHO-Mplus™ Library - A Novel and Powerful Advancement in Biologic Protein Expression,” the 60 minute webinar will begin at 4:00 PM CEST | 10:00 AM EDT | 7:00 AM PDT on Wednesday, June 19, 2013.

Registration URL: https://attendee.gotowebinar.com/register/1073373288445877504
Webinar ID: 123-386-987

In this webinar you will learn:

  •     An overview of the SURE CHO-M production cell line
  •     The construction of the SURE CHO-Mplus™ combinatorial library
  •     How to implement the SURE CHO-Mplus™ Library platform to efficiently advance drug discovery and protein production programs
  •     Case studies utilizing the SURE CHO-Mplus™ Library

Who should attend?

  •     Any scientist working with recombinant protein either as a target or as a future drug
  •     Cell line development scientists and researchers
  •     Biologics development scientists
  •     Cellular biochemists

When:
Wednesday, June 19, 2013
4:00 PM CEST | 10:00 AM EDT | 7:00 AM PDT
50 minute presentation
10 minute Q/A

Webinar Abstract:
The Selexis SURE CHO-Mplus™ Library - A Novel and Powerful Advancement in Biologic Protein Expression

With certain recombinant proteins, optimal expression cannot be achieved by elevated transcription alone. Low productivity can be the result of a myriad of issues including faulty cleavage and protein precipitation, improper folding, metabolic overload, or backlog in protein translocation or vesicle trafficking. Within Selexis’ SURE CHO-Mplus™ Library a variety of cellular pathway components have been modified to address specific bottlenecks, such as aberrant glycosylation, improper protein folding, metabolic or translation issues. The SURE CHO-Mplus™ Library has been shown to significantly improve production levels of a broad range of proteins including difficult-to-express monoclonal antibodies, enzymes, structural proteins and fusion proteins such as Fc-fusions and minibodies.

About the Speaker:
Pierre-Alain Girod, PhD, Chief Scientific Officer
Dr. Girod joined Selexis in 2006 and was promoted to Chief Scientific Officer in 2007. Dr. Girod studied and received his PhD from the University of Lausanne. Prior to joining Selexis, Dr. Girod worked at the Department of Biology at the University of Lausanne in the field of targeted protein degradation. Earlier in his career, Dr. Girod completed a postdoctoral fellowship at the University of Wisconsin-Madison in the degradation of proteins by the ubiquitin pathway. In 1993 he returned to Switzerland where he discovered a family of genetic sequences involved in the epigenetic regulation of genes. This discovery has subsequently been used to by pharmaceutical and biotechnology companies to boost expression of therapeutic proteins.
Where:
Registration URL: https://attendee.gotowebinar.com/register/1073373288445877504
Webinar ID: 123-386-987

About Selexis SA
Headquartered in Geneva, Switzerland, Selexis SA is a global life science company with innovative technologies and world-class expert services for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins. The Company’s SUREtechnology Platform™ is based on Selexis Genetic Elements™ — novel DNA-based elements that control the dynamic organization of chromatin within all mammalian cells and allow for higher and more stable expression of recombinant proteins. Selexis has generated over 1,700 cell lines being used in a variety of programs from drug discovery to late-stage clinical trials.
For more information:

Read the full story at http://www.prweb.com/releases/webinar_therapeutic_drug/cell_line_development/prweb10777507.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Institute for Healthcare Advancement will Honor Four for Excellence in Health Literacy at National Conference
2. Advancement In Door Security Combines Delayed Egress And Latch Retraction In One Panic Hardware Device
3. PharmaSmart® and Kinney Drugs Partner up to Unveil Newest Advancement in Pharmacy-Based Biometric Screening and Mobile Interoperability
4. Joslins Susan Bonner-Weir, Ph.D., named American Association for the Advancement of Science Fellow
5. LaStone Launches Merger with TIR Massage Stone To Further The Advancement of Massage Therapy Education in 2012
6. Silk and cellulose biologically effective for use in stem cell cartilage repair
7. Frequently used biologic agents might cause acute liver injury
8. Men Biologically Programmed to Steer Clear of Friends Wives
9. Dog Study Raises Prospect of Biological Pacemaker for Humans
10. Medicines quality workshop to address standards for microbiological contamination, bioburden control
11. Dr. Daniel Strader of Dallas Designer Smiles Receives Top Reviews as Local Dallas, TX Dentist for Biological Dentistry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
Breaking Medicine Technology: